(Q38455005)

3 September 2017

title

National health care costs of peripheral arterial disease in the Medicare population (English)

1 reference

3 September 2017

4

Beth A Virnig

1 reference

3 September 2017

Alan T Hirsch

1

1 reference

3 September 2017

Lacey Hartman

series ordinal

2

1 reference

3 September 2017

Robert J Town

series ordinal

3

1 reference

3 September 2017

language of work or name

1 reference

1 August 2008

1 reference

3 September 2017

1 reference

3 September 2017

volume

13

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

209-215

1 reference

Medical treatment of peripheral arterial disease and claudication

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

The prevalence of peripheral arterial disease in a defined population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Peripheral arterial disease in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Data validity issues in using claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Smoking cessation in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

Costs and Medical Care Consequences Associated with the Diagnosis of Peripheral Arterial Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X08089277

21 January 2018

Identifiers

DOI

10.1177/1358863X08089277

1 reference

3 September 2017

1 reference